Getinge AB (Getinge AB) ROCE % : 7.20% (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Getinge AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Getinge AB's annualized ROCE % for the quarter that ended in Mar. 2024 was 7.20%.

Getinge AB ROCE % Historical Data

The historical data trend for Getinge AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getinge AB ROCE % Chart

Getinge AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

6.67

14.32

12.02

9.33

9.53

Getinge AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															9.00	4.13	13.00	10.18	7.20

Getinge AB ROCE % Calculation

Getinge AB's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	371.627	/	( ( (5013.683 - 1155.618)	+	(5224.029 - 1285.388) )	/ 2 )
	=	371.627	/	( (3858.065	+	3938.641)	/ 2 )
	=	371.627	/	3898.353
	=	9.53 %

Getinge AB's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	301.212	/	( ( (5224.029 - 1285.388)	+	(5409.507 - 984.411) )	/ 2 )
	=	301.212	/	( ( 3938.641	+	4425.096 )	/ 2 )
	=	301.212	/	4181.8685
	=	7.20 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Getinge AB (OTCPK:GNGBF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Getinge AB ROCE % Related Terms

Thank you for viewing the detailed overview of Getinge AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Getinge AB (Getinge AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (OTCPK:GNGBF) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

GNGBY:USA GETI B:Sweden GETIBs:UK 0GZV:UK GTN:Germany

Address

Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, SE-417 56

Website

https://www.getinge.com

Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (54% of revenue), surgical workflows (32%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.